Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Dow Ends Historic Week Up More Than 2%: Pfizer Inc. (PFE), Intel Corporation (INTC)

Page 1 of 2

The Dow Jones Industrial Average 2 Minute (Dow Jones Indices:.DJI) gained more than 300 points, or 2.18%, this week, and set a new record high in each of the past four days. The blue-chip index rose by another 0.47% today, while the S&P 500 (S&P Indices:.INX) and the NASDAQ both closely followed, gaining 0.45% and 0.38%, respectively.

The markets forged ahead today after the Labor Department announced January’s employment numbers. While December’s numbers were revised lower, to 119,000, January posted 236,000 new jobs, when economists were only expecting 165,000. The increased job number lowered the nation’s unemployment rate to 7.7%.

But even though the markets, in general, moved higher, a number of the Dow’s 30 components ended the day in the red.

Intel Corporation (NASDAQ:INTC)The Dow’s downers
The Dow’s drug giant Pfizer Inc. (NYSE:PFE) lost 0.28% of its value today. Shares fell after the company announced that it has ended its attempt to find a cure for hepatitis C. Pfizer, Gilead Sciences, Inc. (NASDAQ:GILD), and AbbVie, each have been attempting to develop their own hepatitis C drug over the past few years. As of 24 months ago, all three companies seemed equally in contention. But Pfizer Inc. (NYSE:PFE) recently fell behind in development, as its drug failed to perform as successfully as its rivals’ offerings.

Most analysts never expected Pfizer Inc. (NYSE:PFE)’s drug to become a blockbuster, and they don’t believe this will have a major impact on the company down the road.

Both of the Dow’s big banks saw their shares fall today. Bank of America Corp (NYSE:BAC) lost 1.55%, and JPMorgan Chase & Co. (NYSE:JPM) was cut down by 0.89%. Despite the fact that 18 of the 19 financial institutions passed the Federal Reserve’s latest stress test, the financial industry, as a whole, moved lower today.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!